ADC Asia Congress 2025

The ADC 2025 conference by IMAPAC focuses exclusively on targeting the next generation of antibody-drug conjugates, an emergent class of targeted anticancer agents. This conference brings together various specialists involved in the development and clinical application of new solutions for designing drugs and delivering them to patients. Topics explored include issues related to ADC production, toxicity issues, and regulatory aspects, so the reader is offered a broad perspective of the therapeutic possibilities of ADCs. Speakers present technical information on new ADC technologies, and case studies are used to understand the new methodologies. The gathering provides a unique opportunity for industry experts where technical issues can be discussed and innovative solutions and guidelines for ADC advancement shared. Networking sessions add to the overall engagement whereby biopharma decision-makers, researchers, and solution providers work together in ADCs. ADCT—the ADC community gains from exchange on industry trends, pipeline development, and strategies that are reshaping ADC therapies for oncology and other therapeutic indications.